TERNS PHARMACEUTICALS INC (TERN) Forecast, Price Target & Analyst Ratings

NASDAQ:TERN • US8808811074

Current stock price

52.72 USD
-0.07 (-0.13%)
At close:
52.73 USD
+0.01 (+0.02%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TERNS PHARMACEUTICALS INC (TERN).

Forecast Snapshot

Consensus Price Target

Price Target
$55.08
+ 4.48% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.28
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
76.47%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$55.08
Upside
+ 4.48%
From current price of $52.72 to mean target of $55.08, Based on 17 analyst forecasts
Low
$17.17
Median
$57.63
High
$73.50

Price Target Revisions

1 Month
0.00%
3 Months
0.83%

Price Target Summary

17 Wall Street analysts provided a forecast for the next 12 months for TERN. The average price target is 55.08 USD. This implies a price increase of 4.48% is expected in the next year compared to the current price of 52.72.
The average price target has been revised upward by 0.83% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

TERN Current Analyst RatingTERN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

TERN Historical Analyst RatingsTERN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
76.47%
TERN was analyzed by 17 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about TERN.
In the last month the buy percentage fell by 10 points. So the trust of analysts is decreasing.
TERN was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-31Truist SecuritiesDowngrade Buy -> Hold
2026-03-30BarclaysDowngrade Overweight -> Equal-Weight
2026-03-26CitizensDowngrade Market Outperform -> Market Perform
2026-03-26TD CowenDowngrade Buy -> Hold
2026-03-25HC Wainwright & Co.Downgrade Buy -> Neutral
2025-12-11CitizensMaintains Market Outperform -> Market Outperform
2025-12-09MizuhoMaintains Outperform -> Outperform
2025-12-09BMO CapitalMaintains Outperform -> Outperform
2025-12-09OppenheimerMaintains Outperform -> Outperform
2025-12-09BarclaysMaintains Overweight -> Overweight
2025-12-09Truist SecuritiesMaintains Buy -> Buy
2025-12-09HC Wainwright & Co.Maintains Buy -> Buy
2025-11-26CitizensMaintains Market Outperform -> Market Outperform
2025-11-25BarclaysMaintains Overweight -> Overweight
2025-11-19Truist SecuritiesMaintains Buy -> Buy
2025-11-18BMO CapitalMaintains Outperform -> Outperform
2025-11-13MizuhoMaintains Outperform -> Outperform
2025-11-11BarclaysMaintains Overweight -> Overweight
2025-11-04BMO CapitalMaintains Outperform -> Outperform
2025-11-04BarclaysMaintains Overweight -> Overweight
2025-11-04Truist SecuritiesReiterate Buy -> Buy
2025-11-04HC Wainwright & Co.Upgrade Neutral -> Buy
2025-11-03William BlairUpgrade Market Perform -> Outperform
2025-10-23JMP SecuritiesMaintains Market Outperform -> Market Outperform
2025-10-22BarclaysMaintains Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.28
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-7.14%
Number of Analysts
12

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
9.01%

Next Earnings Summary

TERN is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.28 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
TERN revenue by date.TERN revenue by date.
1M
-100.00%		4.029M59.064M
1,365.97%		267.72M
353.27%		343.32M
28.24%		713.04M
107.69%		1.107B
55.25%
EBITDA
YoY % growth
TERN ebitda by date.TERN ebitda by date.
-70M
-280.64%		-36.64M
47.66%		-49.35M
-34.69%		-64.25M
-24.72%		-104.478M
-66.15%		-105.06M
0.70%		-112.742M
-11.02%		-135.836M
-20.48%		-167.76M
-23.50%		-182.07M
-8.53%		-162.792M
10.59%		46.104M
128.32%		204.82M
344.26%		897.5M
338.19%		1.793B
99.78%
EBIT
YoY % growth
TERN ebit by date.TERN ebit by date.
-70.2M
-280.28%		-37.03M
47.25%		-49.86M
-34.65%		-64.802M
-24.41%		-135.246M
-65.34%		-105.442M
0.67%		-115.722M
-13.60%		-138.015M
-19.26%		-164.807M
-19.41%		-174.357M
-5.79%		-267.057M
-53.17%		-111.623M
58.20%		85.315M
176.43%		430.77M
404.92%		779.71M
81.00%
Operating Margin
TERN operating margin by date.TERN operating margin by date.
N/AN/A-4,986.00%N/AN/AN/AN/AN/AN/A-4,327.56%-452.15%-41.69%24.85%60.41%70.43%
EPS
YoY % growth
TERN eps by date.TERN eps by date.
N/AN/A-2.34
28.53%		-1.92
21.79%		-1.36
30.60%		-1.23
11.02%		-1.10
8.85%		-1.22
-18.46%		-1.55
-27.32%		-1.63
-5.06%		-1.59
2.50%		-0.63
60.26%		0.59
193.02%		4.06
590.13%		6.58
62.06%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28
EPS
Q2Q % growth		-0.28
-7.14%		-0.29
-11.57%		-0.32
-18.89%		-0.35
-46.48%		-0.35
-24.50%		-0.36
-23.07%		-0.35
-8.04%		-0.35
1.35%		-0.34
2.94%		-0.34
5.71%		-0.34
2.94%
Revenue
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth		-32.354M
-18.20%		-32.509M
-19.01%		-32.708M
-18.35%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-32.717M
-19.29%		-34.364M
-25.49%		-36.708M
-32.44%		-43.778M
-58.63%		N/AN/AN/AN/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

TERN Yearly Revenue VS EstimatesTERN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
TERN Yearly EPS VS EstimatesTERN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-16.58%
EPS Next 5 Year
6.75%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-16.74%
EBIT Next 5 Year
-9.07%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

TERNS PHARMACEUTICALS INC / TERN Forecast FAQ

What do analysts expect the price target to be for TERNS PHARMACEUTICALS INC (TERN)?

17 analysts have analysed TERN and the average price target is 55.08 USD. This implies a price increase of 4.48% is expected in the next year compared to the current price of 52.72.

When does TERNS PHARMACEUTICALS INC (TERN) report earnings?

TERNS PHARMACEUTICALS INC (TERN) will report earnings on 2026-05-06.

Can you provide the consensus estimates for TERNS PHARMACEUTICALS INC next earnings?

The consensus EPS estimate for the next earnings of TERNS PHARMACEUTICALS INC (TERN) is -0.28 USD and the consensus revenue estimate is 0 USD.

What is the consensus rating for TERN stock?

The consensus rating for TERNS PHARMACEUTICALS INC (TERN) is 76.4706 / 100 . This indicates that analysts generally have a positive outlook on the stock.